{"id":"https://openalex.org/W1498570536","doi":"https://doi.org/10.1111/j.1476-5381.2012.01880.x","title":"Does terfenadine\u2010induced ventricular tachycardia/fibrillation directly relate to its QT prolongation and Torsades de Pointes?","display_name":"Does terfenadine\u2010induced ventricular tachycardia/fibrillation directly relate to its QT prolongation and Torsades de Pointes?","alternate_titles":[],"publication_year":2012,"publication_date":"2012-05-17","ids":{"openalex":"https://openalex.org/W1498570536","doi":"https://doi.org/10.1111/j.1476-5381.2012.01880.x","mag":"1498570536","pmid":"https://pubmed.ncbi.nlm.nih.gov/22300168","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3417462"},"language":"en","primary_location":{"id":"doi:10.1111/j.1476-5381.2012.01880.x","doi":"https://doi.org/10.1111/j.1476-5381.2012.01880.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.2012.01880.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.2012.01880.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1498570536"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.2012.01880.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102991705","display_name":"Hua Rong Lu","orcid":"https://orcid.org/0000-0002-5211-1410","observed_orcids":["https://orcid.org/0000-0002-5211-1410"]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Hua Rong Lu","raw_affiliation_strings":["Center of Excellence for Cardiovascular Safety Research and Mechanistic Pharmacology, Janssen Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium. hlu@its.jnj.com","Center of Excellence for Cardiovascular Safety Research & Mechanistic Pharmacology Janssen, Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center of Excellence for Cardiovascular Safety Research and Mechanistic Pharmacology, Janssen Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium. hlu@its.jnj.com","institution_ids":["https://openalex.org/I137982388"]},{"raw_affiliation_string":"Center of Excellence for Cardiovascular Safety Research & Mechanistic Pharmacology Janssen, Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110035158","display_name":"An N. Hermans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"An N Hermans","raw_affiliation_strings":["Center of Excellence for Cardiovascular Safety Research and Mechanistic Pharmacology, Janssen Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium","Center of Excellence for Cardiovascular Safety Research & Mechanistic Pharmacology Janssen, Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center of Excellence for Cardiovascular Safety Research and Mechanistic Pharmacology, Janssen Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]},{"raw_affiliation_string":"Center of Excellence for Cardiovascular Safety Research & Mechanistic Pharmacology Janssen, Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101456329","display_name":"David J. Gallacher","orcid":"https://orcid.org/0000-0003-2548-3056","observed_orcids":["https://orcid.org/0000-0003-2548-3056"]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David J Gallacher","raw_affiliation_strings":["Center of Excellence for Cardiovascular Safety Research and Mechanistic Pharmacology, Janssen Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium","Center of Excellence for Cardiovascular Safety Research & Mechanistic Pharmacology Janssen, Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center of Excellence for Cardiovascular Safety Research and Mechanistic Pharmacology, Janssen Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]},{"raw_affiliation_string":"Center of Excellence for Cardiovascular Safety Research & Mechanistic Pharmacology Janssen, Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5102991705"],"corresponding_institution_ids":["https://openalex.org/I137982388"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":2.4854,"has_fulltext":true,"cited_by_count":48,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.89988167,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"166","issue":"4","first_page":"1490","last_page":"1502"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11217","display_name":"Cardiac Arrhythmias and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/terfenadine","display_name":"terfenadine","score":1.0},{"id":"https://openalex.org/keywords/ventricular-tachycardia","display_name":"ventricular tachycardia","score":0.8880000114440918},{"id":"https://openalex.org/keywords/ventricular-fibrillation","display_name":"ventricular fibrillation","score":0.9980000257492065},{"id":"https://openalex.org/keywords/torsades-de-pointes","display_name":"torsades de pointes","score":0.9399999976158142},{"id":"https://openalex.org/keywords/qt-interval-prolongation","display_name":"QT prolongation","score":0.8980000019073486},{"id":"https://openalex.org/keywords/drug-induced-arrhythmia","display_name":"drug-induced arrhythmia","score":0.7730000019073486},{"id":"https://openalex.org/keywords/cardiovascular-mortality","display_name":"cardiovascular mortality","score":0.5120000243186951},{"id":"https://openalex.org/keywords/early-afterdepolarizations","display_name":"early afterdepolarizations","score":0.9110000133514404},{"id":"https://openalex.org/keywords/qtc-prolongation","display_name":"QTc prolongation","score":0.43700000643730164}],"concepts":[{"id":"https://openalex.org/C2779303165","wikidata":"https://www.wikidata.org/wiki/Q417909","display_name":"Terfenadine","level":2,"score":0.9676110744476318},{"id":"https://openalex.org/C2780486423","wikidata":"https://www.wikidata.org/wiki/Q1625433","display_name":"Torsades de pointes","level":3,"score":0.9214361906051636},{"id":"https://openalex.org/C2779362680","wikidata":"https://www.wikidata.org/wiki/Q905000","display_name":"hERG","level":3,"score":0.8021061420440674},{"id":"https://openalex.org/C2776331378","wikidata":"https://www.wikidata.org/wiki/Q56002","display_name":"Ventricular tachycardia","level":2,"score":0.7576498985290527},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6284347772598267},{"id":"https://openalex.org/C2781005686","wikidata":"https://www.wikidata.org/wiki/Q848662","display_name":"Ventricular fibrillation","level":2,"score":0.6266582608222961},{"id":"https://openalex.org/C118441451","wikidata":"https://www.wikidata.org/wiki/Q12074763","display_name":"QT interval","level":2,"score":0.6057705879211426},{"id":"https://openalex.org/C2777796741","wikidata":"https://www.wikidata.org/wiki/Q3712521","display_name":"Dofetilide","level":3,"score":0.574249267578125},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.5630811452865601},{"id":"https://openalex.org/C155730078","wikidata":"https://www.wikidata.org/wiki/Q2898697","display_name":"Afterdepolarization","level":4,"score":0.5517647862434387},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5477076768875122},{"id":"https://openalex.org/C2779703243","wikidata":"https://www.wikidata.org/wiki/Q653924","display_name":"Long QT syndrome","level":3,"score":0.47805124521255493},{"id":"https://openalex.org/C2993353509","wikidata":"https://www.wikidata.org/wiki/Q411867","display_name":"Sudden death","level":2,"score":0.4174792766571045},{"id":"https://openalex.org/C2779837460","wikidata":"https://www.wikidata.org/wiki/Q421381","display_name":"Flecainide","level":3,"score":0.4109153151512146},{"id":"https://openalex.org/C2780339425","wikidata":"https://www.wikidata.org/wiki/Q412496","display_name":"Quinidine","level":2,"score":0.4107290506362915},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3372572660446167},{"id":"https://openalex.org/C146403970","wikidata":"https://www.wikidata.org/wiki/Q205729","display_name":"Repolarization","level":3,"score":0.32689395546913147},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.2685527205467224},{"id":"https://openalex.org/C83743174","wikidata":"https://www.wikidata.org/wiki/Q423778","display_name":"Potassium channel","level":2,"score":0.21028843522071838},{"id":"https://openalex.org/C185263204","wikidata":"https://www.wikidata.org/wiki/Q1154774","display_name":"Electrophysiology","level":2,"score":0.12848979234695435}],"mesh":[{"descriptor_ui":"D000200","descriptor_name":"Action Potentials","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000889","descriptor_name":"Anti-Arrhythmia Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000889","descriptor_name":"Anti-Arrhythmia Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000889","descriptor_name":"Anti-Arrhythmia Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001692","descriptor_name":"Biological Transport","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006352","descriptor_name":"Heart Ventricles","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D006352","descriptor_name":"Heart Ventricles","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006352","descriptor_name":"Heart Ventricles","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008133","descriptor_name":"Long QT Syndrome","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D008133","descriptor_name":"Long QT Syndrome","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008133","descriptor_name":"Long QT Syndrome","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D009994","descriptor_name":"Osmolar Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014693","descriptor_name":"Ventricular Fibrillation","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D016171","descriptor_name":"Torsades de Pointes","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D016171","descriptor_name":"Torsades de Pointes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016171","descriptor_name":"Torsades de Pointes","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D016593","descriptor_name":"Terfenadine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016593","descriptor_name":"Terfenadine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016593","descriptor_name":"Terfenadine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017180","descriptor_name":"Tachycardia, Ventricular","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D020517","descriptor_name":"Atrial Appendage","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D020517","descriptor_name":"Atrial Appendage","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D020517","descriptor_name":"Atrial Appendage","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D026941","descriptor_name":"Sodium Channel Blockers","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D026941","descriptor_name":"Sodium Channel Blockers","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D026941","descriptor_name":"Sodium Channel Blockers","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D032383","descriptor_name":"Myocytes, Cardiac","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D032383","descriptor_name":"Myocytes, Cardiac","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D032383","descriptor_name":"Myocytes, Cardiac","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D039563","descriptor_name":"Histamine H1 Antagonists, Non-Sedating","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D039563","descriptor_name":"Histamine H1 Antagonists, Non-Sedating","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D039563","descriptor_name":"Histamine H1 Antagonists, Non-Sedating","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051638","descriptor_name":"Ether-A-Go-Go Potassium Channels","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D051638","descriptor_name":"Ether-A-Go-Go Potassium Channels","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051638","descriptor_name":"Ether-A-Go-Go Potassium Channels","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D057809","descriptor_name":"HEK293 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1111/j.1476-5381.2012.01880.x","doi":"https://doi.org/10.1111/j.1476-5381.2012.01880.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.2012.01880.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.2012.01880.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3481770","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3417462","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3417462","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3417462/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"},{"id":"pmid:22300168","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22300168","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/j.1476-5381.2012.01880.x","doi":"https://doi.org/10.1111/j.1476-5381.2012.01880.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.2012.01880.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.2012.01880.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1498570536.pdf","grobid_xml":"https://content.openalex.org/works/W1498570536.grobid-xml"},"referenced_works_count":49,"referenced_works":["https://openalex.org/W1500785579","https://openalex.org/W1918091678","https://openalex.org/W1968876226","https://openalex.org/W1973512309","https://openalex.org/W1974795857","https://openalex.org/W1977410911","https://openalex.org/W1981860274","https://openalex.org/W1985572222","https://openalex.org/W1999129678","https://openalex.org/W1999804639","https://openalex.org/W2003676394","https://openalex.org/W2005793953","https://openalex.org/W2013302830","https://openalex.org/W2014521635","https://openalex.org/W2029226207","https://openalex.org/W2034786923","https://openalex.org/W2039067546","https://openalex.org/W2044033021","https://openalex.org/W2052085254","https://openalex.org/W2057620029","https://openalex.org/W2068866618","https://openalex.org/W2073134847","https://openalex.org/W2074159517","https://openalex.org/W2076127970","https://openalex.org/W2078999633","https://openalex.org/W2084653113","https://openalex.org/W2087702990","https://openalex.org/W2090153327","https://openalex.org/W2091488037","https://openalex.org/W2110290477","https://openalex.org/W2118646052","https://openalex.org/W2123347511","https://openalex.org/W2126627460","https://openalex.org/W2129262770","https://openalex.org/W2133290235","https://openalex.org/W2137710575","https://openalex.org/W2146152350","https://openalex.org/W2149789485","https://openalex.org/W2150629896","https://openalex.org/W2162589170","https://openalex.org/W2166197749","https://openalex.org/W2169062359","https://openalex.org/W2318973628","https://openalex.org/W2327378923","https://openalex.org/W2403372082","https://openalex.org/W2614168425","https://openalex.org/W2898897524","https://openalex.org/W4210965788","https://openalex.org/W4253853981"],"related_works":["https://openalex.org/W2106230364","https://openalex.org/W2057620029","https://openalex.org/W1586574218","https://openalex.org/W2078999633","https://openalex.org/W2044617162","https://openalex.org/W2072530465","https://openalex.org/W2161862532","https://openalex.org/W2014653527","https://openalex.org/W2008172537","https://openalex.org/W1995553570"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1,187],"PURPOSE:":[2],"Terfenadine":[3,76],"has":[4],"been":[5],"reported":[6],"to":[7,252],"cause":[8],"cardiac":[9,129,222,244],"death.":[10],"Hence,":[11],"we":[12,44],"investigated":[13,29],"its":[14,46],"pro-arrhythmic":[15],"potential":[16],"in":[17,19,30,55,66,82,86,175],"various":[18],"vitro":[20],"models.":[21],"EXPERIMENTAL":[22],"APPROACH:":[23],"Pro-arrhythmic":[24],"effects":[25],"of":[26,125,133,142,153,173,196,204,208],"terfenadine":[27,105,148,174,226],"were":[28],"rabbit":[31,67,83,98],"isolated":[32],"hearts":[33],"and":[34,61,70,78,85,90,102,114,135,165,242],"left":[35,99],"ventricular":[36,68,100,137],"wedge":[37,101],"preparations.":[38],"Also,":[39],"using":[40],"whole-cell":[41],"patch-clamp":[42],"recording,":[43],"examined":[45],"effect":[47],"on":[48,62],"the":[49,63,93,97,112,126,143,171,176,183,194,232,238],"human":[50,71,87],"ether-\u00e0-go-go-related":[51],"gene":[52],"(hERG)":[53],"current":[54,65],"HEK293":[56],"cells":[57,69],"transfected":[58],"with":[59],"hERG":[60,230],"I(Na)":[64,81,209],"atrial":[72,88],"myocytes.":[73],"KEY":[74],"RESULTS:":[75],"concentration-":[77],"use-dependently":[79],"inhibited":[80,92],"myocytes":[84,89],"also":[91],"hERG.":[94],"In":[95],"both":[96],"heart":[103,184],"preparations,":[104],"at":[106,117],"1":[107],"\u00b5M":[108,147],"only":[109],"slightly":[110],"prolonged":[111],"QT-":[113],"JT-intervals":[115],"but":[116],"10":[118,146],"\u00b5M,":[119],"it":[120,180],"caused":[121,201],"a":[122,150,216,228,250],"marked":[123],"widening":[124],"QRS":[127],"complex,":[128],"wavelength":[130,245],"shortening,":[131],"incidences":[132],"in-excitability":[134],"non-TdP-like":[136,197,235],"tachycardia/fibrillation":[138],"(VT/VF)":[139],"without":[140],"prolongation":[141],"QT/JT-interval.":[144],"At":[145],"elicited":[149],"lower":[151],"incidence":[152],"early":[154],"afterdepolarizations":[155],"versus":[156],"non-":[157],"Torsades":[158],"de":[159],"Pointes":[160],"(TdP)-like":[161],"VT/VF":[162,236],"(100%":[163],"incidence),":[164],"did":[166],"not":[167],"induce":[168],"TdPs.":[169],"Although":[170],"concentration":[172],"tissue-bath":[177],"was":[178],"low,":[179],"accumulated":[181],"within":[182],"tissue.":[185],"CONCLUSION":[186],"IMPLICATIONS:":[188],"Our":[189],"data":[190],"suggest":[191],"that:":[192],"(i)":[193],"induction":[195],"VT/VF,":[198],"which":[199],"is":[200,227],"by":[202],"slowing":[203],"conduction":[205],"via":[206],"blockade":[207],"(like":[210],"Class":[211],"Ic":[212],"flecainide),":[213],"may":[214],"constitute":[215],"more":[217],"important":[218],"risk":[219,233,239],"for":[220,234,240],"terfenadine-induced":[221,254],"death;":[223],"(ii)":[224],"although":[225],"potent":[229],"blocker,":[231],"exceeds":[237],"TdPs;":[241],"(iii)":[243],"(\u03bb)":[246],"could":[247],"serve":[248],"as":[249],"biomarker":[251],"predict":[253],"VT/VF.":[255]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1498570536","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
